Agios Pharmaceuticals Inc...

NASDAQ: AGIO · Real-Time Price · USD
37.00
0.32 (0.87%)
At close: Aug 15, 2025, 3:59 PM
37.14
0.38%
After-hours: Aug 15, 2025, 07:37 PM EDT

Agios Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
650.08M 665.99M 673.73M 674.31M -364.93M -352.62M -352.09M -219.62M -210.04M -218.04M -231.8M -366.91M -369.42M -360.41M -356.51M -355.58M -370.3M -377.99M
Depreciation & Amortization
5.25M 5.58M 5.65M 5.69M 5.97M 6.18M 6.62M 7.03M 7.39M 7.88M 8.56M 8.95M 9.18M 9.24M 9.24M 9.71M 9.91M 9.99M
Stock-Based Compensation
48.1M 44.97M 42.85M 45.76M 43.69M 43.86M 44.77M 42.42M 44.5M 43.92M 49.3M 49.45M 50.44M 54.16M 53.51M 58.48M 64.74M 70.29M
Other Working Capital
-62.17M -49.7M -43.02M 12.87M -4.56M -11.39M 26.64M 21.03M 18.95M 22.08M -6.67M -18.09M -23.66M -37.37M -38.69M -20.16M -3.75M 3.52M
Other Non-Cash Items
-1.08B -1.08B -1.03B -1B 78.98M 64.3M 48.76M -104.75M -123.08M -123.25M -119.35M 10.35M 10.85M 10.71M 9.54M 12.48M 19.44M 19.73M
Deferred Income Tax
n/a n/a n/a -23.59M -22.11M -25.07M -25.07M -1.48M -2.96M n/a n/a -2.48M -10.89M -57.41M -86.27M -82.3M -72.83M -25.96M
Change in Working Capital
-27.4M -17.28M -46.26M 5.6M -15.96M -22.27M -19.06M -13.34M -15.25M -17.67M -16.43M -27.02M -31.64M -40.59M -36.82M -15.42M -6.61M -2.21M
Operating Cash Flow
-406M -401.46M -389.84M -329.16M -306.59M -300.75M -296.06M -289.74M -299.44M -306.93M -309.48M -327.41M -341.24M -384.31M -407.32M -372.62M -355.65M -306.15M
Capital Expenditures
-3.03M -2.31M -1.69M -952K -18.4M -18.24M -18.5M -18.38M -547K -2.48M -4.88M -9.27M -9.21M -7.53M -5.74M -2.26M -7.48M -11.47M
Cash Acquisitions
-40K -40K n/a n/a 17.54M -29.58M -29.47M 103.28M -18.33M 28.79M 28.64M -104.11M n/a n/a n/a n/a n/a n/a
Purchase of Investments
-1.5B -1.47B -1.54B -1.43B -534.05M -533.64M -417.93M -576.05M -655.52M -803.22M -1.03B -1.21B -1.49B -1.67B -1.38B -1.08B -866.33M -563.98M
Sales Maturities Of Investments
816.61M 737.92M 818.38M 854.43M 847.89M 857.21M 674.68M 687.37M 814.91M 1B 1.15B 1.28B 1.23B 1.03B 829.8M 691.73M 591.95M 614.2M
Other Investing Acitivies
1.08B 1.13B 1.13B 1.22B 116.86M 126.58M 184.54M 88.79M 209.22M 246.84M 165.08M 75.16M -261.7M -644.34M 1.18B 1.34B 1.46B 1.78B
Investing Cash Flow
393.19M 351.47M 363.44M 508.11M 296.66M 306.54M 239.57M 227.01M 291.74M 327.43M 243.26M 65.89M -270.91M -651.87M 1.25B 1.41B 1.52B 1.84B
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a -83K -167K -250K -331K -53K -572K -573K -578K -859K -340K -342K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -19.05M -273.44M -802.49M -802.49M -783.44M -529.05M n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
9.16M 10.2M 14.44M 10.45M 9.69M 8.83M 5.43M 4.69M 4.08M 3.86M 2.68M 2.84M 5.58M -497.81M -491.75M -491.35M -491.83M 263.74M
Financial Cash Flow
9.16M 10.2M 14.44M 10.45M 9.69M 8.83M 5.43M 4.61M 3.91M 3.61M 2.35M -16.26M -268.43M -771.82M -765.77M -746.6M -492.17M 263.39M
Net Cash Flow
-3.65M -39.8M -11.96M 189.4M -235K 14.63M -51.05M -58.12M -3.79M 24.11M -63.87M -277.77M -880.58M -1.81B 75.69M 295.37M 673.27M 1.8B
Free Cash Flow
-409.02M -403.77M -391.53M -330.11M -324.99M -318.99M -314.56M -308.12M -299.99M -309.4M -314.36M -336.68M -350.45M -391.84M -413.06M -374.88M -363.13M -317.62M